The market’s reaction to Salesforce’s latest quarterly report was unmistakable — a 23 percent surge that ranked as the second-best trading day in the company’s public-market history. But peel back the layers of that rally, and the picture becomes considerably more nuanced than the headline number suggests.
The Book Gain at the Heart of the Beat
Salesforce delivered adjusted earnings per share of $5.90 for the second fiscal quarter of 2027, blowing past the analyst consensus of $3.27. Revenue climbed 11 percent to $11.35 billion. Yet buried in that earnings figure is a critical distinction: roughly $2.6 billion of the quarter’s $3.53 billion net income — up 87 percent year over year — came from a paper gain tied to the company’s stake in Anthropic, not from operations.
Strip out that mark-to-market effect, and adjusted EPS lands closer to $3.37, representing growth of roughly 16 percent rather than the eye-popping 103 percent the headline number implies. The distinction matters for anyone trying to gauge whether this is a genuine inflection point or a one-time accounting artifact.
A Partnership That Signals Strategic Humility
The same week brought news that Salesforce and Anthropic are deepening their ties through a partnership dubbed “Claudeforce,” embedding Anthropic’s Claude model directly into Salesforce’s ecosystem, including Slack and Agentforce. Some 37 pre-built sales skills will let users draft emails, update records, and execute guided actions. Pilot customers are already testing the integration, with an open beta slated for September 2026 and additional pre-built skills expected from late 2026.
The move reads as a pragmatic acknowledgment that Salesforce can’t go it alone in AI. Rather than risk falling behind rivals in foundation-model capabilities, the company is opting for strategic partnership over solitary development — a sensible posture given the capital intensity of frontier AI research.
The Operating Metrics That Actually Matter
Agentforce, Salesforce’s AI-agent platform, reached $1.5 billion in annual recurring revenue, up 240 percent, according to figures shared at the Deutsche Bank Technology Conference. Data 360 and related products contributed roughly $3.9 billion in ARR. The Informatica acquisition, closed in fiscal 2026, added $456 million in revenue — evidence that Salesforce is methodically building out its data infrastructure to support the AI strategy.
The current remaining performance obligation (cRPO) grew 14 percent to $33.5 billion, a forward-looking indicator that suggests demand remains healthy. Management also raised its full-year revenue guidance to a range of $46.1 billion to $46.4 billion, up from the prior $45.9 billion to $46.2 billion, and lifted EPS guidance to $16.67 to $16.71 per share.
Should investors sell immediately? Or is it worth buying Salesforce?
But D.A. Davidson flagged a less celebrated detail: organic growth excluding the Informatica contribution slipped to 6.4 percent, down from 8.7 percent previously. That deceleration is the kind of number that tends to get lost in the noise of a double-digit share-price pop.
Confidence Signals and Cautious Voices
Management returned $364 million to shareholders via dividends while continuing its $25 billion buyback program — a signal that free cash flow remains ample even amid partnership investments and acquisitions.
The analyst community responded with a flurry of target-price revisions. Jefferies reaffirmed its “Buy” rating and lifted its target to $300, while JPMorgan raised its price target to $265 with an “Overweight” stance. Citi’s Tyler Radke, however, moved his target from $187 to $204 while keeping a “Neutral” rating — a reminder that not everyone is ready to declare a new era. D.A. Davidson similarly raised its target but held at “Neutral.”
Technical Signals Point to Caution
The stock’s recent run has been remarkable — up 32 percent over the past 30 days — but it remains 4.6 percent in the red on a year-to-date basis, underscoring just how skeptical investors had grown about Salesforce’s AI positioning before this quarter. The 14-day RSI sits at 79.4, firmly in overbought territory, and annualized 30-day volatility of 78 percent suggests the market is trading this name with considerable nervousness. The shares now trade roughly 39 percent above their 50-day moving average.
Large enterprise wins — including deals with the US Army, Deutsche Telekom, and FIFA — alongside a reported tripling of Agentforce demand lend credibility to the growth narrative. But the bears have a legitimate counter: if organic growth continues to soften and Claudeforce proves to be more announcement than revenue engine, the current enthusiasm could unwind quickly.
The September 2026 open beta of Claudeforce will serve as the next concrete test of whether this partnership translates into measurable revenue. Until then, investors are left weighing a genuinely strong quarter against the uncomfortable reality that a meaningful chunk of the earnings beat — and the resulting stock pop — came from a mark-to-market adjustment rather than the core business.
Ad
Salesforce Stock: Buy or Sell?! New Salesforce Analysis from August 28 delivers the answer:
The latest Salesforce figures speak for themselves: Urgent action needed for Salesforce investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 28.
Salesforce: Buy or sell? Read more here...
